MB Endometodas Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| - |
| 0 |
| 2023 |
|---|
| 2,453 |
| - |
| 1,700 |
| 1,700 |
| - |
| 81.61 |
| 69.30 |
| 2,700 |
| 24 |
| 0 |
| 2,724 |
| 1.10 |
| 0.01 |
| - |
| - |
| 69.30 |
| 1,700 |
| 2024 |
|---|
| 4,687 |
| - |
| -2,228 |
| -2,228 |
| - |
| -38.49 |
| -47.54 |
| 472 |
| 344 |
| 0 |
| 816 |
| 0.10 |
| 0.73 |
| - |
| - |
| -49.69 |
| -2,329 |
| 2024 |
|---|
| 4,687 |
| - |
| -2,228 |
| -2,228 |
| - |
| -38.49 |
| -47.54 |
| 472 |
| 344 |
| 0 |
| 816 |
| 0.10 |
| 0.73 |
| - |
| - |
| -49.69 |
| -2,329 |
Turnover (€)
2024
Turnover (€)
4,687 €91 % *
Sales per employee (€)
-Profit before tax (€)
-2,228 €-231 % *
Net Profit (€)
-2,228 €-231 % *
Profit per employee (€)
-Total profitability (%)
-38.49 %-147.16 % *
Net profitability (%)
-47.54 %-168.60 % *
Equity (€)
472 €-83 % *
Amounts Payable And Liabilities (€)
344 €1,333 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
816 €-70 % *
Working capital requirement
0.10 -90.91 % *
Debt-to-equity ratio
0.73 7,200.00 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-49.69 %-171.70 % *
EBIT (€)
-2,329 €-237 % *
